Esperion Therapeutics, Inc. (ESPR): 25-NSE filed Jul 13, 2026

Form type

25-NSE

Filing date

Jul 13, 2026

Accession number

0001354457-26-000668

Filer

Esperion Therapeutics, Inc. (CIK 1434868)